Header Ads

Stock Ticker HSGX

HSGX could have big news coming very soon.  Company meets with the FDA to see approval for their drug NeoCart.  The company did announce that Phase 3 Trials did not hit its primary endpoint.

NeoCart is a cell-therapy based implant designed to help restore and heal knee cartilage through the use of the patients own cells.

Medium - High Risk Swing Trade


No comments

Powered by Blogger.